Catalyst Wire Dossier Catalyst Wire Dossier

Gene Modified T Cells (CAR-T therapy)

CAR-T · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene Modified T Cells (CAR-T therapy), covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

See pricing